Beximco Pharmaceuticals Ltdis A Prominent Bangladeshi Multinational Pharmaceutical Company And A Subsidiary Of The Beximco Conglomerateestablished In 1976 And Starting Operations In 1980It Is Headquartered In Dhanmondidhakathe Company Became The First Bangladeshi Firm Listed On The London Stock Exchange S Alternative Investment Market In 2005Beximco Pharma Specializes In Manufacturing And Marketing Branded Generic Drugsfocusing On Treatments For Various Conditionsincluding Aidscancerasthmahypertensionand Diabetes With A Diverse Portfolio Of Over 500 Productsbeximco Pharma Includes Well Known Brands Such As Napafilmetand Emorivirthe First Oral Covid 19 Antiviral Authorized In Bangladeshthe Company Exports To Over 50 Countries And Emphasizes Affordability And Accessibilityparticularly In Emerging Marketsunder The Leadership Of Managing Director Iqbal Ahmedbeximco Pharma Has Achieved Significant Milestonesincluding Being The First Bangladeshi Firm To Sell Drugs In The Us Market And Developing Complex Generics And Biosimilars
Germany
